胰高血糖素在自动化胰岛素输送中的作用。
Role of Glucagon in Automated Insulin Delivery.
机构信息
Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Harold Schnitzer Diabetes Health Center, 3181 Southwest Sam Jackson Park Road, L607, Portland, OR 97239-3098, USA.
Department of Biomedical Engineering, Oregon Health & Science University, Mail Code: CH13B, 3303 Southwest Bond Avenue, Portland, OR 97239, USA.
出版信息
Endocrinol Metab Clin North Am. 2020 Mar;49(1):179-202. doi: 10.1016/j.ecl.2019.10.008. Epub 2019 Dec 10.
Abstract
Treatment of type 1 diabetes with exogenous insulin often results in unpredictable daily glucose variability and hypoglycemia, which can be dangerous. Automated insulin delivery systems can improve glucose control while reducing burden for people with diabetes. One approach to improve treatment outcomes is to incorporate the counter-regulatory hormone glucagon into the automated delivery system to help prevent the hypoglycemia that can be induced by the slow pharmacodynamics of insulin action. This article explores the advantages and disadvantages of incorporating glucagon into dual-hormone automated hormone delivery systems.
摘要
用外源性胰岛素治疗 1 型糖尿病常常导致日常血糖变化不可预测和低血糖，这可能很危险。自动化胰岛素输送系统可以改善血糖控制，同时减轻糖尿病患者的负担。一种改善治疗效果的方法是将抗胰岛素激素胰高血糖素纳入自动化输送系统，以帮助预防胰岛素作用缓慢引起的低血糖。本文探讨了将胰高血糖素纳入双激素自动化激素输送系统的优缺点。
相似文献
1
Role of Glucagon in Automated Insulin Delivery.胰高血糖素在自动化胰岛素输送中的作用。
Endocrinol Metab Clin North Am. 2020 Mar;49(1):179-202. doi: 10.1016/j.ecl.2019.10.008. Epub 2019 Dec 10.
2
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.双激素人工胰腺、单激素人工胰腺与常规胰岛素泵治疗对 1 型糖尿病患者血糖控制的比较：一项开放标签随机对照交叉试验。
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26. doi: 10.1016/S2213-8587(14)70226-8. Epub 2014 Nov 27.
3
Factors influencing the effectiveness of glucagon for preventing hypoglycemia.影响胰高血糖素预防低血糖有效性的因素。
J Diabetes Sci Technol. 2010 Nov 1;4(6):1305-10. doi: 10.1177/193229681000400603.
4
Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.与不进行剂量调整及动态血糖监测胰岛素泵治疗相比，运动期间进行剂量调整的双激素人工胰腺随机试验。
Diabetes Obes Metab. 2016 Nov;18(11):1110-1119. doi: 10.1111/dom.12707. Epub 2016 Aug 15.
5
Role of Dual-Hormone Closed-Loop Delivery System in the Future.双激素闭环输送系统在未来的作用。
Diabetes Technol Ther. 2016 Aug;18(8):452-4. doi: 10.1089/dia.2016.0259. Epub 2016 Aug 8.
6
Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.使用液体稳定胰高血糖素制剂的双激素闭环系统与仅胰岛素闭环系统对比预测性低血糖暂停系统：一项开放标签、门诊、单中心、交叉、随机对照试验。
Diabetes Care. 2020 Nov;43(11):2721-2729. doi: 10.2337/dc19-2267. Epub 2020 Sep 9.
7
Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.夜间低血糖感知障碍的 1 型糖尿病患者应用双重和单激素人工胰腺控制血糖：一项随机对照试验。
Diabetes Technol Ther. 2018 Mar;20(3):189-196. doi: 10.1089/dia.2017.0353. Epub 2018 Feb 2.
8
Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.随机门诊试验：使用可穿戴传感器适应运动的单激素和双激素闭环系统。
Diabetes Care. 2018 Jul;41(7):1471-1477. doi: 10.2337/dc18-0228. Epub 2018 May 11.
9
Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.双激素人工胰腺、单激素人工胰腺或传统胰岛素泵治疗在儿童和青少年 1 型糖尿病患者中的门诊过夜血糖控制：一项开放标签、随机对照试验。
Lancet Diabetes Endocrinol. 2015 Aug;3(8):595-604. doi: 10.1016/S2213-8587(15)00141-2. Epub 2015 Jun 8.
10
Automated Insulin Delivery-The Light at the End of the Tunnel.自动胰岛素输注——曙光在前
J Pediatr. 2017 Jul;186:17-28.e9. doi: 10.1016/j.jpeds.2017.02.055. Epub 2017 Apr 7.
引用本文的文献
1
Type 1 diabetes - What's new in prevention and therapeutic strategies?1 型糖尿病 - 预防和治疗策略的新进展？
Pediatr Endocrinol Diabetes Metab. 2023;29(3):196-201. doi: 10.5114/pedm.2023.132028.
2
Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series.混合闭环控制管理 1 型糖尿病胃轻瘫：病例系列。
J Diabetes Sci Technol. 2021 Nov;15(6):1216-1223. doi: 10.1177/19322968211035447. Epub 2021 Aug 11.
3
Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives.考虑人为因素的自动化胰岛素输送容错策略：当前和未来的观点。
J Diabetes Sci Technol. 2021 Nov;15(6):1224-1231. doi: 10.1177/19322968211029297. Epub 2021 Jul 21.
4
Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.双激素人工胰腺治疗 1 型糖尿病：最新进展与未来方向。
Artif Organs. 2021 Sep;45(9):968-986. doi: 10.1111/aor.14023. Epub 2021 Jul 15.
5
Algorithms for Automated Insulin Delivery: An Overview.自动胰岛素输送算法：概述。
J Diabetes Sci Technol. 2022 Sep;16(5):1228-1238. doi: 10.1177/19322968211008442. Epub 2021 May 6.
本文引用的文献
1
Long-Term Safety and Tolerability of Dasiglucagon, a Stable-in-Solution Glucagon Analogue.溶液稳定型胰高血糖素类似物达西高血糖素的长期安全性和耐受性
Diabetes Technol Ther. 2019 Feb;21(2):94-96. doi: 10.1089/dia.2018.0363.
2
Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study.运动后用胰岛素泵治疗的 1 型糖尿病患者对小剂量胰高血糖素的葡萄糖反应得到保存：一项随机交叉研究。
Diabetologia. 2019 Apr;62(4):582-592. doi: 10.1007/s00125-018-4807-8. Epub 2019 Jan 14.
3
Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.小剂量胰高血糖素作为预防 1 型糖尿病运动性低血糖的新方法。
Diabetes Care. 2018 Sep;41(9):1909-1916. doi: 10.2337/dc18-0051. Epub 2018 May 18.
4
Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.随机门诊试验：使用可穿戴传感器适应运动的单激素和双激素闭环系统。
Diabetes Care. 2018 Jul;41(7):1471-1477. doi: 10.2337/dc18-0228. Epub 2018 May 11.
5
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.人工胰腺治疗 1 型糖尿病门诊患者：系统评价和荟萃分析。
BMJ. 2018 Apr 18;361:k1310. doi: 10.1136/bmj.k1310.
6
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue.稳定液态胰高血糖素：超越紧急低血糖救治
J Diabetes Sci Technol. 2018 Jul;12(4):847-853. doi: 10.1177/1932296818757795. Epub 2018 Feb 8.
7
Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.夜间低血糖感知障碍的 1 型糖尿病患者应用双重和单激素人工胰腺控制血糖：一项随机对照试验。
Diabetes Technol Ther. 2018 Mar;20(3):189-196. doi: 10.1089/dia.2017.0353. Epub 2018 Feb 2.
8
Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.先前饮酒对 1 型糖尿病患者小剂量胰高血糖素葡萄糖反应的影响：一项随机、安慰剂对照、交叉研究。
Diabetes Care. 2018 Apr;41(4):797-806. doi: 10.2337/dc17-1458. Epub 2018 Jan 22.
9
Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems.双激素人工胰腺：与单激素系统相比的优势和局限性。
Diabet Med. 2018 Apr;35(4):450-459. doi: 10.1111/dme.13581. Epub 2018 Feb 11.
10
The effect of exercise on sleep in adults with type 1 diabetes.运动对 1 型糖尿病成人睡眠的影响。
Diabetes Obes Metab. 2018 Feb;20(2):443-447. doi: 10.1111/dom.13065. Epub 2017 Sep 14.
Zotero 插件